Fennec Pharmaceuticals Inc. (FENC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Fennec Pharmaceuticals Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -22.59x | -395.64x | -18.58x | -11.08x | -6.66x | -9.75x |
| P/B Ratio | 6.28x | -29.38x | -25.65x | -98.19x | 7.26x | 6.07x |
| P/S Ratio | 4.93x | 3.63x | 14.03x | 171.11x | 0.00x | 1038.79x |
| Profitability | ||||||
| Gross Margin | 91.6% | 93.3% | 94.1% | 94.4% | 0.0% | 100.0% |
| Operating Margin | -14.2% | 5.4% | -60.1% | -1471.6% | 0.0% | -10520.6% |
| Net Margin | -21.8% | -0.9% | -75.5% | -1544.9% | 0.0% | -10652.4% |
| EBITDA Margin | -16.7% | 10.1% | -58.2% | -1471.5% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.34x | 6.38x | 3.56x | 5.80x | 13.54x | 13.39x |
| Quick Ratio | 6.19x | 6.22x | 3.27x | 5.67x | 13.54x | 13.39x |
| Leverage | ||||||
| Debt/Equity | 0.00x | -3.29x | -2.66x | -9.69x | 0.32x | 0.00x |
YoY = year-over-year change. Source: FMP..